Vaseem Palejwala
Chief Tech/Sci/R&D Officer en TIZIANA LIFE SCIENCES LTD .
Cargos activos de Vaseem Palejwala
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Chief Tech/Sci/R&D Officer | 01/01/2022 | - |
Historial de carrera de Vaseem Palejwala
Antiguos cargos conocidos de Vaseem Palejwala.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Corporate Officer/Principal | 01/01/2017 | 01/01/2019 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2012 | 01/01/2017 |
| Sanofi-Synthelabo, Inc. | Corporate Officer/Principal | 01/01/2001 | 01/01/2012 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01/01/2017 | - |
Formación de Vaseem Palejwala.
| University of Mumbai | Undergraduate Degree |
| University of Baroda | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| India | 3 |
| Bermudas | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Empresas privadas | 3 |
|---|---|
| Sanofi-Synthelabo, Inc. | Health Technology |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Vaseem Palejwala
- Experiencia
